Vilin Bio Med Ltd
NSE: VILINBIO BSE: 78871
₹36.65
(-1.87%)
Wed, 08 Apr 2026, 09:23 am
Market Cap521.03M
PE Ratio203.84
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2005
- The company was incorporated as a public limited company.
- The company received a certificate of commencement of business.
2006
- The company started its first commercial production.
2007
- The company expanded phase 2 of the beta lactum facility with 16000 sft for tablet, capsule, and dry syrup sections.
2010
- The company received more than 1000 molecule drug approvals with different strengths in therapeutics.
2012
- The company developed 120 different styles of packings, including physician sample packs.
2014
- The company added a sachet section in the non-beta lactum facility.
2015
- The company introduced more than 20 different punches in different dimensions of the tablet to meet customer requirements.
2021
- New promoters were inducted to strengthen the management of the company.
2022
- The company appointed professionals on the board to strengthen the board and corporate governance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800